Conneqt Health Limited
Research Conneqt Health Limited (CQT) on Bullrun: market cap AUD 14.49M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCQT
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryMedical Devices
- CurrencyAUD
- Market capAUD 14.49M
- Financial periodFY2025
Valuation Snapshot
latest market cap is AUD 14.49M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -0.04 | n/a | n/a | n/a |
| FY2024 | AUD 10.91M | -AUD 6.77M | -AUD 7.84M | 92.7% | -0.04 | AUD 481.43K | AUD 3.86M | AUD 4.09M |
| FY2023 | AUD 4.60M | -AUD 18.89M | -AUD 12.08M | 80.3% | -0.13 | AUD 716.32K | AUD 4.29M | -AUD 748.41K |
| FY2022 | AUD 4.07M | -AUD 11.81M | -AUD 9.59M | 75.2% | -0.1 | AUD 1.46M | AUD 2.14M | AUD 6.61M |
| FY2021 | AUD 2.70M | -AUD 5.55M | -AUD 4.35M | 66.5% | n/a | AUD 3.67M | AUD 1.44M | AUD 7.91M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | AUD 14.49M | n/a | n/a | n/a |
About Conneqt Health Limited
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Conneqt Health Limited's market cap?
Conneqt Health Limited's market capitalization is AUD 14.49M.
What does Conneqt Health Limited do?
Conneqt Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices.